Anglo French Drugs & Industries Limited Launches AFD: Pulmo Range in Respiratory Care

Mumbai (Maharashtra) [India], October 19: Anglo-French Drugs & Industries Limited, one of the leading organizations in the Pharma industry, has announced that it has launched new products in the pharma division: – AFD Pulmo Range in respiratory care. The range of the products that are launched are AFD-PULMO-AZI: anti-infective: azithromycin molecule which is one of […]

PNN
PNN Verified Media or Organization • 26 May, 2026 Agency
Oct 19, 2022 • 9:15 PM
P
Press Release
NEWS CARD
Logo
Anglo French Drugs & Industries Limited Launches AFD: Pulmo Range in Respiratory Care
“Anglo French Drugs & Industries Limited Launches AFD: Pulmo Range in Respiratory Care”
Favicon
Read more on dailyoutluk.com
19 Oct 2022
https://www.dailyoutluk.com/anglo-french-drugs-industries-limited-launches-afd-pulmo-range-in-respiratory-care
Copied
Anglo French Drugs & Industries Limited Launches AFD: Pulmo Range in Respiratory Care

Mumbai (Maharashtra) [India], October 19: Anglo-French Drugs & Industries Limited, one of the leading organizations in the Pharma industry, has announced that it has launched new products in the pharma division: – AFD Pulmo Range in respiratory care. The range of the products that are launched are AFD-PULMO-AZI: anti-infective: azithromycin molecule which is one of the preferred molecules in respiratory tract infections. AFD-PULMO-LS: Cough syrup for productive cough which is the largest segment in cough preparations. AFD-PULMO-A2: Combination of Acebrophylline and Acetylcysteine a fast-growing segment related to severe cases of bronchitis especially when there is hypersecretion of mucus in the respiratory tract leading to breathing disorders.

The range that the company launched has already received approval from Drug Control Department.

Mr Abhay Kanoria, Chairman & Managing Director, Anglo French Drugs & Industries Limited, “We have launched these products in India keeping in mind the respiratory problems that have arisen among children and adults with the emergence of covid.  Our product is of superior quality that will keep us ahead in the market among the other players in the pharma industry. We are very positive about the growth of our pharma division with the launch of our new products in the Pulmo range.”

history This is an archived post. The information provided may be outdated.

PNN Verified Media or Organization • 26 May, 2026 Agency

Agency News

Recommended Posts

home Home amp_stories Web Stories local_fire_department Trending play_circle Videos mark_email_unread Newsletter